" class="no-js "lang="en-US"> MHRA Archives - Medtech Alert
Friday, March 29, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Azafaros Receives Additional Regulatory Designations for AZ-3102 from FDA, EMA and MHRA

Azafaros today announced its progress in ongoing interactions with Health Authorities regarding its lead drug […]

Celadon Pharmaceuticals Announces Approval of GMP Registration by MHRA

Celadon Pharmaceuticals, a UK-based pharmaceutical company focused on the research, cultivation, manufacturing and sale of […]

Evusheld Approved to Prevent COVID-19 in People Whose Immune Response is Poor

A new medicine, Evusheld (tixagevimab/cilgavimab), has today been authorised for COVID-19 prevention by the Medicines […]

MHRA Approves Xevudy (sotrovimab), a COVID-19 Treatment Found to Cut Hospitalisation and Death by 79%

Another COVID-19 treatment, Xevudy (sotrovimab), has today been approved by the Medicines and Healthcare products […]

First Oral Antiviral for COVID-19, Lagevrio (molnupiravir), Approved by MHRA

The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and […]

First Monoclonal Antibody Treatment for COVID-19 Approved for Use in the UK

Following on from a thorough review of the evidence carried out by the MHRA, and […]

The MHRA Concludes Positive Safety Profile for Pfizer/BioNTech Vaccine in 12- to 15-year-olds

An extension to the current UK approval of the Pfizer/BioNTech COVID-19 vaccine that allows its […]

UK Medicines Regulator Issues its First Authorisation Under Project Orbis

A post-surgery treatment for lung cancer will be the first to receive an authorisation from […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more